GEMMATI, Donato
 Distribuzione geografica
Continente #
NA - Nord America 23.858
AS - Asia 13.895
EU - Europa 9.856
SA - Sud America 2.253
Continente sconosciuto - Info sul continente non disponibili 465
AF - Africa 320
OC - Oceania 33
Totale 50.680
Nazione #
US - Stati Uniti d'America 23.085
SG - Singapore 5.125
CN - Cina 3.380
IT - Italia 2.796
DE - Germania 1.880
BR - Brasile 1.768
VN - Vietnam 1.537
UA - Ucraina 1.249
HK - Hong Kong 1.172
GB - Regno Unito 860
PL - Polonia 787
TR - Turchia 693
FI - Finlandia 540
BD - Bangladesh 465
FR - Francia 456
CA - Canada 449
JP - Giappone 387
RU - Federazione Russa 333
IN - India 306
SE - Svezia 293
MX - Messico 211
AR - Argentina 177
ID - Indonesia 172
NL - Olanda 131
ZA - Sudafrica 117
IQ - Iraq 101
ES - Italia 81
BE - Belgio 73
PK - Pakistan 71
CO - Colombia 69
EC - Ecuador 67
VE - Venezuela 62
UZ - Uzbekistan 57
CZ - Repubblica Ceca 52
MA - Marocco 51
SA - Arabia Saudita 50
SM - San Marino 49
MY - Malesia 43
EG - Egitto 41
CH - Svizzera 40
AT - Austria 39
LT - Lituania 39
PH - Filippine 39
AE - Emirati Arabi Uniti 36
IR - Iran 36
CL - Cile 34
PY - Paraguay 33
IE - Irlanda 31
AU - Australia 26
KE - Kenya 26
NP - Nepal 26
TN - Tunisia 24
JM - Giamaica 22
CR - Costa Rica 21
UY - Uruguay 21
RO - Romania 20
AZ - Azerbaigian 17
IL - Israele 17
JO - Giordania 17
TH - Thailandia 15
GR - Grecia 14
KZ - Kazakistan 14
PT - Portogallo 14
LK - Sri Lanka 13
PE - Perù 13
TW - Taiwan 13
DZ - Algeria 12
KR - Corea 12
LB - Libano 12
SN - Senegal 12
TT - Trinidad e Tobago 12
DO - Repubblica Dominicana 11
GT - Guatemala 11
OM - Oman 11
PS - Palestinian Territory 11
AL - Albania 10
SK - Slovacchia (Repubblica Slovacca) 10
EU - Europa 9
BG - Bulgaria 8
BO - Bolivia 8
DK - Danimarca 8
ET - Etiopia 8
HN - Honduras 8
RS - Serbia 8
BY - Bielorussia 7
GE - Georgia 7
KW - Kuwait 7
QA - Qatar 7
A2 - ???statistics.table.value.countryCode.A2??? 6
HU - Ungheria 6
NI - Nicaragua 6
BH - Bahrain 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
GD - Grenada 4
NG - Nigeria 4
NO - Norvegia 4
PA - Panama 4
AO - Angola 3
CG - Congo 3
Totale 50.160
Città #
Singapore 3.003
Ashburn 2.367
Woodbridge 1.674
Fairfield 1.522
San Jose 1.459
Jacksonville 1.365
Chandler 1.317
Hong Kong 1.154
Beijing 1.065
Santa Clara 1.063
Houston 996
Ann Arbor 978
Council Bluffs 779
Warsaw 773
Seattle 625
Wilmington 616
Ho Chi Minh City 497
New York 472
Cambridge 446
Izmir 422
Los Angeles 411
Munich 411
Nanjing 390
Dallas 368
Tokyo 365
Hanoi 356
Ferrara 337
Milan 331
Princeton 292
Lauterbourg 271
Boardman 235
Helsinki 190
Rome 159
São Paulo 158
Orem 147
Mexico City 145
San Diego 142
Shanghai 141
Mcallen 130
Buffalo 129
Bologna 123
Montréal 122
The Dalles 119
Shenyang 117
Toronto 117
London 116
Dearborn 99
Jakarta 98
Nanchang 96
Montreal 93
Chicago 91
Changsha 90
Tianjin 90
Turku 88
Da Nang 87
Hebei 86
Bremen 81
Chennai 80
Denver 77
Phoenix 77
Brooklyn 75
Jiaxing 74
Hefei 69
Frankfurt am Main 68
Haiphong 67
Rio de Janeiro 67
Brussels 65
Johannesburg 61
Boston 56
Naples 55
Atlanta 53
Berlin 53
Jinan 53
Redwood City 53
Düsseldorf 51
Greven 51
San Francisco 50
Stockholm 50
Belo Horizonte 49
Bottrop 49
Guangzhou 49
Norwalk 49
Tashkent 49
Falls Church 48
Baghdad 46
Manchester 45
Moscow 41
Nuremberg 39
Poplar 38
Brasília 37
Dong Ket 37
Falkenstein 37
Mountain View 37
Amsterdam 36
Kunming 35
Zhengzhou 35
San Mateo 33
Verona 32
Mumbai 31
Ningbo 30
Totale 31.601
Nome #
Nanobiomaterials for vascular biology and wound management: a review 1.322
FISIOPATOLOGIA DELL'EMOSTASI E DELLA COAGULAZIONE 737
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 590
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 490
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 373
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 364
Fisiopatologia della Coagulazione. 294
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 294
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 294
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 285
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 279
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 275
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival 275
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 272
Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers 270
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 266
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 266
Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes: new insights from a case-control study 265
Realizzazione di un DNA-Array di varianti genetiche nelle lesioni croniche di origine vascolare 264
Crosstalk between adipokines and paraoxonase 1: A new potential axis linking oxidative stress and inflammation 264
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 260
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 258
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 258
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 257
FOLATE GENE VARIANTS AFFECT METHOTREXATE-RELATED TOXICITY IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS 256
Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration 255
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 254
High throughput array technologies: Expanding applications from clinics to applied research 251
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 250
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 248
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 246
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 244
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 242
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 241
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 240
Fisiopatologia dell'Emostasi e della Coagulazione 238
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 238
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 236
Genetic predictors of response to photodynamic therapy 235
DNA-array of gene variants in venous leg ulcers: Detection of prognostic indicators 234
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 233
Influence of gene polymorphisms in ulcer healing process after superficial venous surgery 232
MTHFR 677C→T polymorphism and risk of coronary heart disease: A meta-analysis 231
Prognostic role of Factor XIII gene variants in nonhealing venous leg ulcers 231
A deep vein thrombosis in an adolescent diabetic boy: A case report | [Descrizione di un caso di trombosi venosa profonda in un adolescente diabetico] 229
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 228
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 227
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 225
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 224
A photometric assay for factor-XIII in chronic hepatopathies. 223
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 223
Effects of electromagnetic fields on proteoglycan metabolism of bovine articular cartilage explants 220
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis 219
Effects of physical stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bovine articular cartilage 218
Influence of Genetic Polymorphisms in Ulcer Healing Process after Superficial Venous Surgery 217
Polymorphisms in the genes coding for iron binding and transporting proteins are Associated with Disability, Severity, and Early Progression in Multiple Sclerosis. 217
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 217
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 215
Quantitive evaluation of dentin sialoprotein (DSP) using microbeads - A potential early marker of root resorption 215
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 214
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 212
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 211
Investigation of in vitro cytotoxicity of the redox state of ionic iron in neuroblastoma cells. 210
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 209
GENETIC SUSCEPTIBILITY IN VENOUS LEG ULCER 208
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 206
Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review 205
Nanoengineering Approaches to Design Advanced Dental Materials for Clinical Applications. 203
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 202
TIME- AND DOSE-DEPENDENT EFFECTS OF CHRONIC WOUND FLUID ON HUMAN ADULT DERMAL FIBROBLASTS 202
Genetics and epigenetics of one-carbon metabolism pathway in autism spectrum disorder: A sex-specific brain epigenome? 199
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 198
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 197
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 197
circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis 196
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 196
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 195
Partial gene deletion in a family with factor X deficiency 195
Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes. 193
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 193
Folate: metabolism, biochemistry and role in disease processes. 190
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 190
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients 188
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities 187
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 186
Meta-analysis of multiple sclerosis microarray data reveals dysregulation in RNA splicing regulatory genes 186
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 185
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 185
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 181
Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS) 181
A modified functional global test to measure PC, PS activities and the APC-resistance phenotype 179
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 179
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 179
What is potentially the right factor XIII for venous leg ulcer treatment? 178
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 178
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 178
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 178
The eclipse effect: the overlapping of varicose vein and C282Y heterozygous gene mutation 178
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 177
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 177
Totale 24.805
Categoria #
all - tutte 210.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.626
Totale 219.778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.799 0 380 272 98 247 124 118 116 101 253 301 789
2022/20233.045 325 212 78 374 494 500 167 277 314 32 172 100
2023/20241.602 146 188 68 46 160 247 49 110 33 53 75 427
2024/20256.871 202 155 539 214 886 497 239 422 1.168 893 941 715
2025/202619.311 1.657 855 1.606 2.515 2.613 1.276 2.175 1.119 1.836 2.017 1.086 556
2026/20271.577 604 973 0 0 0 0 0 0 0 0 0 0
Totale 50.680